Paul Tudor Jones's DYN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 77,031 shares of Dyne Therapeutics, Inc. (DYN) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in DYN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 147,621 shares. Largest reduction occurred in Q2 2025, reducing 81,266 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Dyne Therapeutics (DYN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dyne Therapeutics (DYN) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -70,590 | Reduce 47.82% | 77,031 | $18.13 |
| Q4 2025 | +147,621 | New Buy | 147,621 | $19.56 |
| Q2 2025 | -81,266 | Sold Out | 0 | $0.00 |
| Q1 2025 | +38,002 | Add 87.84% | 81,266 | $10.46 |
| Q4 2024 | -7,219 | Reduce 14.30% | 43,264 | $23.56 |
| Q3 2024 | +3,414 | Add 7.25% | 50,483 | $35.92 |
| Q2 2024 | -9,892 | Reduce 17.37% | 47,069 | $35.29 |
| Q1 2024 | +56,961 | New Buy | 56,961 | $28.39 |
| Q2 2023 | -61,003 | Sold Out | 0 | $0.00 |
| Q1 2023 | +746 | Add 1.24% | 61,003 | $0.01 |
| Q4 2022 | +34,057 | Add 129.99% | 60,257 | $0.01 |
| Q3 2022 | -43,863 | Reduce 62.61% | 26,200 | $12.71 |
| Q2 2022 | +14,932 | Add 27.08% | 70,063 | $6.87 |
| Q1 2022 | +16,016 | Add 40.95% | 55,131 | $9.63 |
| Q4 2021 | +39,115 | New Buy | 39,115 | $11.89 |
| Q3 2021 | -23,230 | Sold Out | 0 | $0.00 |
| Q2 2021 | -50,528 | Reduce 68.51% | 23,230 | $21.05 |
| Q1 2021 | +62,992 | Add 585.10% | 73,758 | $15.52 |
| Q4 2020 | -2,708 | Reduce 20.10% | 10,766 | $20.99 |
| Q3 2020 | +13,474 | New Buy | 13,474 | $20.19 |
Paul Tudor Jones's Dyne Therapeutics Investment FAQs
Paul Tudor Jones first purchased Dyne Therapeutics, Inc. (DYN) in Q3 2020, acquiring 13,474 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Dyne Therapeutics, Inc. (DYN) for 20 quarters since Q3 2020.
Paul Tudor Jones's largest addition to Dyne Therapeutics, Inc. (DYN) was in Q4 2025, adding 147,621 shares worth $2.89 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 77,031 shares of Dyne Therapeutics, Inc. (DYN), valued at approximately $1.4 M.
As of the Q1 2026 filing, Dyne Therapeutics, Inc. (DYN) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Dyne Therapeutics, Inc. (DYN) was 147,621 shares, as reported at the end of Q4 2025.